Chengdu Kangnuoxing Biopharma,Inc.
6 clinical trials · Sponsor
◉ Watch Chengdu Kangnuoxing Biopharma,Inc.
| Record | Firm | Date |
|---|---|---|
| Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis (NCT07678931) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-08-01 |
| A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD) (NCT07544862) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-06-02 |
| Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) (NCT07617324) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-06-01 |
| A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (NCT07483268) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-05-29 |
| A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR) (NCT07459556) | Chengdu Kangnuoxing Biopharma,Inc. | 2026-03-01 |
| Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid (NCT07210554) | Chengdu Kangnuoxing Biopharma,Inc. | 2025-11-11 |
Track Chengdu Kangnuoxing Biopharma,Inc. automatically
Every clearance here is in the API, with alerts when new ones post.